H Fujita1, H Yamabe, M Yokoyama. 1. First Department of Internal Medicine, Kobe University School of Medicine, Japan. fujitaf@sannet.ne.jp
Abstract
OBJECTIVES: We tested the hypothesis that an exogenous supplement of L-arginine could alleviate coronary perfusion abnormality during exercise in patients with angina pectoris and normal coronary arteries. METHODS AND RESULTS: Twelve patients underwent exercise thallium-201 scintigraphy without medication (control) and after intravenous administration of L-arginine. Exercise time was prolonged in the L-arginine study compared with the control (482 s vs 540 s, P < .05). TI-201 extent score was improved in the L-arginine study (0.33 vs 0.26, P < .05), and the severity score was also improved (23.7 vs 16.9, P < .05). In 7 of the 12 patients whose TI-201 redistribution disappeared in the L-arginine study, the percent increase in serum L-citrulline concentration during exercise was larger than that of the remaining 5 patients (18% vs 0.9%, P < .01). The percent reduction in epicardial coronary diameter in response to acetylcholine was also greater in the former group (28.3% vs 11.1%, P < .05). CONCLUSION: Exogenous L-arginine improved myocardial perfusion during exercise in a subset of patients with angina pectoris and normal coronary arteries, probably by increasing production of nitric oxide.
OBJECTIVES: We tested the hypothesis that an exogenous supplement of L-arginine could alleviate coronary perfusion abnormality during exercise in patients with angina pectoris and normal coronary arteries. METHODS AND RESULTS: Twelve patients underwent exercise thallium-201 scintigraphy without medication (control) and after intravenous administration of L-arginine. Exercise time was prolonged in the L-arginine study compared with the control (482 s vs 540 s, P < .05). TI-201 extent score was improved in the L-arginine study (0.33 vs 0.26, P < .05), and the severity score was also improved (23.7 vs 16.9, P < .05). In 7 of the 12 patients whose TI-201 redistribution disappeared in the L-arginine study, the percent increase in serum L-citrulline concentration during exercise was larger than that of the remaining 5 patients (18% vs 0.9%, P < .01). The percent reduction in epicardial coronary diameter in response to acetylcholine was also greater in the former group (28.3% vs 11.1%, P < .05). CONCLUSION: Exogenous L-arginine improved myocardial perfusion during exercise in a subset of patients with angina pectoris and normal coronary arteries, probably by increasing production of nitric oxide.
Authors: B Koifman; Y Wollman; N Bogomolny; T Chernichowsky; A Finkelstein; G Peer; J Scherez; M Blum; S Laniado; A Iaina Journal: J Am Coll Cardiol Date: 1995-11-01 Impact factor: 24.094
Authors: G M Rosano; P Ponikowski; S Adamopoulos; P Collins; P A Poole-Wilson; A J Coats; J C Kaski Journal: Am J Cardiol Date: 1994-06-15 Impact factor: 2.778
Authors: S M Bode-Böger; R H Böger; H Alfke; D Heinzel; D Tsikas; A Creutzig; K Alexander; J C Frölich Journal: Circulation Date: 1996-01-01 Impact factor: 29.690
Authors: Prem Soman; Devang M Dave; James E Udelson; Hui Han; Husam Z Ouda; Ayan R Patel; Richard H Karas; Jeffrey T Kuvin Journal: J Nucl Cardiol Date: 2006-11 Impact factor: 5.952
Authors: Claudio Napoli; Sharon Williams-Ignarro; Filomena de Nigris; Lilach O Lerman; Francesco P D'Armiento; Ettore Crimi; Russell E Byrns; Amelia Casamassimi; Alessandro Lanza; Fernando Gombos; Vincenzo Sica; Louis J Ignarro Journal: Proc Natl Acad Sci U S A Date: 2006-06-26 Impact factor: 11.205
Authors: Filomena de Nigris; Lilach O Lerman; Sharon Williams Ignarro; Giacomo Sica; Amir Lerman; Wulf Palinski; Louis J Ignarro; Claudio Napoli Journal: Proc Natl Acad Sci U S A Date: 2003-01-13 Impact factor: 11.205
Authors: Claudio Napoli; Sharon Williams-Ignarro; Filomena De Nigris; Lilach O Lerman; Loredana Rossi; Carmen Guarino; Gelsomina Mansueto; Francesco Di Tuoro; Orlando Pignalosa; Gaetano De Rosa; Vincenzo Sica; Louis J Ignarro Journal: Proc Natl Acad Sci U S A Date: 2004-05-28 Impact factor: 11.205